# MMCTOP: A Multimodal Textualization and Mixture-of-Experts Framework for Clinical Trial Outcome Prediction

arXiv: https://arxiv.org/abs/2512.21897 · HTML: https://mlsanity.com/paper/2512.21897/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Placed in Medical and biomedical MoE, one of 12 directions in Mixture-of-experts.
- Builds on 20 of its 58 references that are in the map.
- First posted on arXiv 26 Dec 2025.

## Placed in

- Mixture-of-experts / [Medical and biomedical MoE](https://mlsanity.com/moe/medical-and-biomedical-moe/)

## Builds on (most cited first, 20 of 20)

- [BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding](https://mlsanity.com/paper/1810.04805/) (2018)
- [Sentence-BERT: Sentence Embeddings using Siamese BERT-Networks](https://mlsanity.com/paper/1908.10084/) (2019)
- [Outrageously Large Neural Networks: The Sparsely-Gated Mixture-of-Experts Layer](https://mlsanity.com/paper/1701.06538/) (2017)
- [Switch Transformers: Scaling to Trillion Parameter Models with Simple and Efficient Sparsity](https://mlsanity.com/paper/2101.03961/) (2021)
- [BioBERT: a pre-trained biomedical language representation model for biomedical text mining](https://mlsanity.com/paper/1901.08746/) (2019)
- [Graph Neural Networks: A Review of Methods and Applications](https://mlsanity.com/paper/1812.08434/) (2018)
- [MoleculeNet: A Benchmark for Molecular Machine Learning](https://mlsanity.com/paper/1703.00564/) (2017)
- [Large Language Models: A Survey](https://mlsanity.com/paper/2402.06196/) (2024)
- [ChemBERTa: Large-Scale Self-Supervised Pretraining for Molecular Property Prediction](https://mlsanity.com/paper/2010.09885/) (2020)
- [From Sparse to Soft Mixtures of Experts](https://mlsanity.com/paper/2308.00951/) (2023)
- [Modeling polypharmacy side effects with graph convolutional networks](https://mlsanity.com/paper/1802.00543/) (2018)
- [A Survey on Mixture of Experts in Large Language Models](https://mlsanity.com/paper/2407.06204/) (2024)
- [Deep EHR: A Survey of Recent Advances in Deep Learning Techniques for Electronic Health Record (EHR) Analysis](https://mlsanity.com/paper/1706.03446/) (2017)
- [A Comprehensive Survey of Mixture-of-Experts: Algorithms, Theory, and Applications](https://mlsanity.com/paper/2503.07137/) (2025)
- [Matching Patients to Clinical Trials with Large Language Models](https://mlsanity.com/paper/2307.15051/) (2023)
- [HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Data](https://mlsanity.com/paper/2102.04252/) (2021)
- [Think Inside the JSON: Reinforcement Strategy for Strict LLM Schema Adherence](https://mlsanity.com/paper/2502.14905/) (2025)
- [Multimodal Clinical Trial Outcome Prediction with Large Language Models](https://mlsanity.com/paper/2402.06512/) (2024)
- [Automatically Labeling Clinical Trial Outcomes: A Large-Scale Benchmark for Drug Development](https://mlsanity.com/paper/2406.10292/) (2024)
- [PyTrial: Machine Learning Software and Benchmark for Clinical Trial Applications](https://mlsanity.com/paper/2306.04018/) (2023)

## Abstract (arXiv)

Addressing the challenge of multimodal data fusion in high-dimensional biomedical informatics, we propose MMCTOP, a MultiModal Clinical-Trial Outcome Prediction framework that integrates heterogeneous biomedical signals spanning (i) molecular structure representations, (ii) protocol metadata and long-form eligibility narratives, and (iii) disease ontologies. MMCTOP couples schema-guided textualization and input-fidelity validation with modality-aware representation learning, in which domain-specific encoders generate aligned embeddings that are fused by a transformer backbone augmented with a drug-disease-conditioned sparse Mixture-of-Experts (SMoE). This design explicitly supports specialization across therapeutic and design subspaces while maintaining scalable computation through top-k routing. MMCTOP achieves consistent improvements in precision, F1, and AUC over unimodal and multimodal baselines on benchmark datasets, and ablations show that schema-guided textualization and selective expert routing contribute materially to performance and stability. We additionally apply temperature scaling to obtain calibrated probabilities, ensuring reliable risk estimation for downstream decision support. Overall, MMCTOP advances multimodal trial modeling by combining controlled narrative normalization, context-conditioned expert fusion, and operational safeguards aimed at auditability and reproducibility in biomedical informatics.
